| 16/05 | Myovant Sciences Opens Laboratory, HQ in Philadelphia; Shares Rise |  |
| 16/05 | Spirovant Launches State-of-the-Art Laboratory and Headquarters | |
| 16/05 | Urovant Sciences presents new data from EMPOWUR study, advancing knowledge of the treat.. | |
| 16/05 | Urovant Sciences Presents Interim Data from Phase 2a Study of Investigational Novel Gen.. | |
| 11/05 | MYOVANT SCIENCES LTD. Management's Discussion and Analysis of Financial Condition and .. | |
| 10/05 | Myovant Sciences and Accord Healthcare, Ltd. Enter into Exclusive License Agreement to .. | |
| 10/05 | TRANSCRIPT : Myovant Sciences Ltd., Q4 2022 Earnings Call, May 10, 2022 | |
| 10/05 | MYOVANT SCIENCES : Fiscal Q4 Earnings Snapshot | |
| 10/05 | Earnings Flash (MYOV) MYOVANT SCIENCES Reports Q4 Revenue $57.6M | |
| 10/05 | Myovant Sciences Ltd. Reports Earnings Results for the Fourth Quarter Ended March 31, 2.. | |
| 10/05 | Myovant Sciences Announces Corporate Updates and Financial Results for Fourth Fiscal Qu.. | |
| 10/05 | Myovant Sciences Ltd. Reports Earnings Results for the Full Year Ended March 31, 2022 | |
| 09/05 | Myovant Sciences Enters European License Deal With Accord Healthcare for Prostate Cance.. | |
| 09/05 | Myovant Sciences and Pfizer Provide Update on Supplemental New Drug Application (sNDA) .. | |
| 09/05 | Myovant Sciences and Accord Healthcare, Ltd. Enter into Exclusive License Agreement to .. | |
| 09/05 | Myovant Sciences and Accord Healthcare, Ltd. Enter into Exclusive License Agreement to .. | |
| 09/05 | Myovant Sciences and Accord Healthcare, Ltd. Enter into Exclusive License Agreement to .. | |
| 06/05 | Myovant, Pfizer Say FDA Extends Review Period for Myfembree's Supplemental New Drug App.. | |
| 06/05 | Altavant sciences presents data showing potential for combination of rodatristat ethyl .. | |
| 06/05 | Myovant Sciences and Pfizer Provide Update on Supplemental New Drug Application (sNDA) .. | |
| 06/05 | Myovant Sciences and Pfizer Provide Update on Supplemental New Drug Application (sNDA) .. | |
| 06/05 | MYOVANT, PFIZER : FDA Extends Review of Myfembree in Endometriosis | |
| 02/05 | Altavant sciences presented data at ishlt showing potency and distribution of bronchiol.. | |
| 02/05 | Myovant Sciences' Prostate Cancer Drug Receives European Commission Approval | |
| 30/04 | Myovant Sciences Announces European Commission Approval for ORGOVYX® (relugolix) for th.. | |
| 30/04 | Myovant Sciences Announces European Commission Approval for ORGOVYX® (relugolix) for th.. | |
| 30/04 | Myovant Sciences Ltd. Announces European Commission Approval for Orgovyx for the Treatm.. | |
| 26/04 | MYOVANT SCIENCES TO HOST FOURTH FISC : 30 a.m. Eastern Time on May 10, 2022 | |
| 20/04 | Urovant Sciences Announces Publication of EMPOWUR Trial Subgroup Analysis Showing Simil.. | |
| 14/04 | Urovant Sciences to Present Interim Data from Phase 2a Study of Potential Novel Gene Th.. | |
| 13/04 | Sumitomo Pharma Co., Ltd. - Myovant Sciences and Pfizer Provide Update on Supplemental .. | |
| 13/04 | Sumitomo Dainippon Unit's New Drug Application with US FDA Hits Roadblock | |
| 12/04 | Kohl's, PG&E rise; CarMax, Myovant fall | |
| 12/04 | SECTOR UPDATE : Health Care Stocks Ending Near Intra-Day Lows | |
| 12/04 | Pfizer, Myovant Sciences Stocks Drop After FDA Flags Deficiencies in Supplemental New D.. | |
| 12/04 | Top Midday Decliners | |
| 12/04 | SECTOR UPDATE : Health Care Stocks Drifting Lower Tuesday Afternoon | |
| 12/04 | SECTOR UPDATE : Health Care | |
| 12/04 | GLOBAL MARKETS LIVE : Honda, Shopify, Meta, ASOS, Gilead Sciences... | |
| 12/04 | Myovant Sciences Stock Hits 52-Week Low After FDA Notice for Myfembree | |
| 12/04 | Inflation data ease investors' fears | |
| 12/04 | Wall Street Set for Gains; Consumer Prices Accelerate in March | |
| 12/04 | SECTOR UPDATE : Health Care Stocks Higher Premarket Tuesday | |
| 12/04 | SECTOR UPDATE : Health Care | |
| 12/04 | Myovant Sciences Shares Drop 20% After FDA Notice for Myfembree | |
| 12/04 | Top Premarket Decliners | |
| 12/04 | Pfizer, Myovant Sciences Say FDA Flags Certain Deficiencies in Supplemental New Drug Ap.. | |
| 12/04 | Myovant Sciences and Pfizer Provide Update on Supplemental New Drug Application for MYF.. | |
| 25/03 | MYOVANT SCIENCES LTD. : Change in Directors or Principal Officers, Financial Statements an.. | |
| 08/03 | TRANSCRIPT : Myovant Sciences Ltd. Presents at 42nd Annual Cowen Health Care Conference, M.. | |
| 25/02 | Myovant Sciences Receives Positive European Medicines Agency Opinion for Orgovyx to Tre.. | |
| 25/02 | Myovant Sciences Receives Positive CHMP Opinion for ORGOVYX® (relugolix) for the Treatm.. | |
| 25/02 | Myovant Sciences Receives Positive CHMP Opinion for Orgovyx® for the Treatment of Advan.. | |
| 18/02 | TRANSCRIPT : Myovant Sciences Ltd. Presents at 11th SVB Leerink Annual Global Healthcare C.. | |
| 10/02 | Sumitomo Dainippon Pharma and Sumitovant Biopharma Initiate Phase 1 Study on New Drug C.. | |
| 07/02 | Myovant Sciences to Present at Upcoming Investor Conferences | |
| 26/01 | TRANSCRIPT : Myovant Sciences Ltd., Q3 2022 Earnings Call, Jan 26, 2022 | |
| 26/01 | MYOVANT SCIENCES : Fiscal Q3 Earnings Snapshot | |
| 26/01 | Myovant Sciences Ltd. Reports Earnings Results for the Third Quarter and Nine Months En.. | |
| 26/01 | Myovant Sciences Fiscal Q3 Loss Narrows, Revenue Climbs | |
| 26/01 | MYOVANT SCIENCES : Announces Financial Results for Third Quarter of Fiscal Year 2021 and C.. | |
| 26/01 | MYOVANT SCIENCES LTD. : Results of Operations and Financial Condition (form 8-K) | |
| 26/01 | Earnings Flash (MYOV) MYOVANT SCIENCES Reports Q3 Revenue $54.4M | |
| 26/01 | Myovant Sciences Announces Financial Results for Third Quarter of Fiscal Year 2021 and .. | |
| 12/01 | TRANSCRIPT : Myovant Sciences Ltd. Presents at JPMorgan 40th Annual Healthcare Conference,.. | |
| 12/01 | MYOVANT SCIENCES TO HOST THIRD FISCA : 30 a.m. Eastern Time on January 26, 2022 | |
| 10/01 | MYOVANT SCIENCES : Announces Preliminary Financial Results for Third Quarter of Fiscal Yea.. | |
| 10/01 | Myovant Sciences Announces Preliminary Financial Results for Third Quarter of Fiscal Ye.. | |
| 10/01 | Myovant Sciences Ltd. Provides Revenue Guidance for the Three Months Ended December 31,.. | |
| 03/01 | Myovant Sciences to Present at the 40th Annual J.P. Morgan Healthcare Conference | |
| 2021 | Myovant Sciences to Participate in the Evercore ISI 4th Annual HealthCONx Conference | |
| 2021 | MYOVANT SCIENCES LTD. : Change in Directors or Principal Officers, Submission of Matters t.. | |
| 2021 | Myovant Sciences Ltd. Announces Kathleen Sebelius Does Not Stand for Re-Election | |
| 2021 | Nancy Valente, M.D. Joins Myovant Sciences' Board of Directors | |
| 2021 | Myovant Sciences Appoints Nancy Valente as Independent Member of its Board of Directors.. | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Italiano
Nederlands (Nederland)
Nederlands (België)
bourse
Rapport
